Skip to content
The FDA Under Pressure episode artwork

Aug 26, 2020 16 min

The FDA Under Pressure

from Prognosis: Misconception Hosted by Bloomberg

This weekend, Stephen Hahn, the commissioner of the U.S. Food and Drug Administration, attracted criticism when he substantially overstated the benefits of an experimental Covid-19 therapy. At a press conference with Trump, Hahn said that a treatment using blood plasma from recovered patients could save 35 of every 100 people who would have died. Those high-profile remarks were incorrect, and they were repeated by others in the Trump administration. Hahn late Monday clarified some of what the data on blood plasma actually show. But the episode has raised questions about how the agency will review a vaccine, as well as its scientific independence. Senior Editor for Health Care Drew Armstrong spoke to Hahn about the agency’s role in an increasingly politicized federal virus response.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

The FDA Under Pressure

0:00 16:05

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Prognosis: Misconception?

This episode is 16 minutes long.

When was this Prognosis: Misconception episode published?

This episode was published on August 26, 2020.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Prognosis: Misconception episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.